• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性类似物方法应用于苯二氮䓬受体配体的药效团识别。

The active analog approach applied to the pharmacophore identification of benzodiazepine receptor ligands.

作者信息

Tebib S, Bourguignon J J, Wermuth C G

机构信息

Department of Molecular Pharmacochemistry, CNRS et Unité 44 de l'INSERM, Strasbourg, France.

出版信息

J Comput Aided Mol Des. 1987 Jul;1(2):153-70. doi: 10.1007/BF01676959.

DOI:10.1007/BF01676959
PMID:2848099
Abstract

Applied to seven potent benzodiazepine-receptor ligands belonging to chemically different classes, the active analog approach allowed the stepwise identification of the pharmacophoric pattern associated with the recognition by the benzodiazepine receptor. A unique pharmacophore model was derived which involves six critical zones: (a) a pi-electron rich aromatic (PAR) zone; (b) two electron-rich zones delta 1 and delta 2 placed at 5.0 and 4.5 A respectively from the reference centroid in the PAR zone; (c) a freely rotating aromatic ring (FRA) region; (d) an out-of-plane region (OPR), strongly associated with agonist properties; and (e) an additional hydrophobic region (AHR). The model accommodates all presently known ligands of the benzodiazepine receptor, identifies sensitivity to steric hindrance close to the delta 1 zone, accounts for R and S differential affinities and distinguishes requirements for agonist versus non-agonist activity profiles.

摘要

将活性类似物方法应用于七种化学类别不同的强效苯二氮䓬受体配体,逐步确定了与苯二氮䓬受体识别相关的药效团模式。由此得出了一个独特的药效团模型,该模型涉及六个关键区域:(a) 富π电子芳香(PAR)区;(b) 两个富电子区δ1和δ2,分别位于PAR区中距参考质心5.0 Å和4.5 Å处;(c) 一个可自由旋转的芳香环(FRA)区域;(d) 一个与激动剂特性密切相关的面外区域(OPR);以及(e) 一个额外的疏水区域(AHR)。该模型涵盖了目前所有已知的苯二氮䓬受体配体,确定了靠近δ1区对空间位阻的敏感性,解释了R和S的不同亲和力,并区分了激动剂与非激动剂活性谱的要求。

相似文献

1
The active analog approach applied to the pharmacophore identification of benzodiazepine receptor ligands.活性类似物方法应用于苯二氮䓬受体配体的药效团识别。
J Comput Aided Mol Des. 1987 Jul;1(2):153-70. doi: 10.1007/BF01676959.
2
Determinants of recognition of ligands binding to benzodiazepine receptor/GABA(A) receptors initiating sedation.启动镇静作用的与苯二氮䓬受体/GABA(A)受体结合的配体识别的决定因素。
Eur J Pharmacol. 2000 Aug 11;401(3):271-87. doi: 10.1016/s0014-2999(00)00462-3.
3
Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site.苯二氮䓬受体反向激动剂位点药效团的合成与计算机辅助分析。
J Med Chem. 1990 Sep;33(9):2343-57. doi: 10.1021/jm00171a007.
4
Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.GABAA/苯二氮䓬受体亚型的分子药效团/受体模型研究:取代β-咔啉在重组αxβ3γ2亚型上的结合亲和力及通过比较分子场分析的定量构效关系研究
Drug Des Discov. 1999 Jul;16(1):55-76.
5
Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore.新型3-取代β-咔啉作为苯二氮䓬受体配体的合成:探索苯二氮䓬受体药效基团
J Med Chem. 1988 Sep;31(9):1854-61. doi: 10.1021/jm00117a029.
6
Development of a comprehensive pharmacophore model for the benzodiazepine receptor.苯二氮䓬受体综合药效团模型的开发。
Drug Des Discov. 1995 Jan;12(3):193-248.
7
Development of a 3D pharmacophore for nonspecific ligand recognition of alpha1, alpha2, alpha3, alpha5, and alpha6 containing GABA(A)/benzodiazepine receptors.用于非特异性识别含α1、α2、α3、α5和α6的GABA(A)/苯二氮䓬受体的三维药效团的开发。
Bioorg Med Chem. 2000 Jul;8(7):1799-807. doi: 10.1016/s0968-0896(00)00112-7.
8
Synthetic and computer assisted analysis of the pharmacophore for agonists at benzodiazepine receptors.苯二氮䓬受体激动剂药效基团的合成与计算机辅助分析
Life Sci. 1991;49(3):207-16. doi: 10.1016/0024-3205(91)90005-v.
9
Molecular structure of Ro15-1788 and a model for the binding of benzodiazepine receptor ligands. Structural identification of common features in antagonists.Ro15 - 1788的分子结构以及苯二氮䓬受体配体结合模型。拮抗剂共同特征的结构鉴定。
Mol Pharmacol. 1985 Aug;28(2):178-84.
10
Benzodiazepine-induced hyperphagia: development and assessment of a 3D pharmacophore by computational methods.苯二氮䓬类药物诱导的食欲亢进:通过计算方法开发和评估三维药效团
J Biomol Struct Dyn. 2000 Apr;17(5):769-78. doi: 10.1080/07391102.2000.10506566.

引用本文的文献

1
Identification and Empiric Evaluation of New Inhibitors of the Multidrug Transporter P-Glycoprotein (ABCB1).鉴定和经验评估多药转运蛋白 P-糖蛋白(ABCB1)的新型抑制剂。
Int J Mol Sci. 2023 Mar 10;24(6):5298. doi: 10.3390/ijms24065298.
2
A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model.α5γ-氨基丁酸A(GABA(A))苯二氮䓬受体模型更新药效团综述。
Int J Med Chem. 2015;2015:430248. doi: 10.1155/2015/430248. Epub 2015 Nov 10.
3
The future of molecular dynamics simulations in drug discovery.

本文引用的文献

1
Ligands for benzodiazepine receptors with positive and negative efficacy.具有正向和负向效力的苯二氮䓬受体配体。
Biochem Pharmacol. 1984 Mar 15;33(6):859-62. doi: 10.1016/0006-2952(84)90438-6.
2
Quinazolines and 1,4-benzodiazepines. 92. Conformational recognition of the receptor by 1,4-benzodiazepines.
Mol Pharmacol. 1983 Nov;24(3):425-8.
3
Distance geometry analysis of the benzodiazepine binding site.苯二氮䓬类药物结合位点的距离几何分析
Mol Pharmacol. 1982 Jul;22(1):11-9.
药物发现中分子动力学模拟的未来。
J Comput Aided Mol Des. 2012 Jan;26(1):15-26. doi: 10.1007/s10822-011-9517-y. Epub 2011 Dec 20.
4
Evaluating molecular similarity using reduced representations of the electron density.使用电子密度的简化表示来评估分子相似性。
J Mol Model. 2005 Jun;11(3):237-47. doi: 10.1007/s00894-005-0264-7. Epub 2005 May 12.
5
Differential affinity of dihydroimidazoquinoxalines and diimidazoquinazolines to the alpha 1 beta 2 gamma 2 and alpha 6 beta 2 gamma 2 subtypes of cloned GABAA receptors.二氢咪唑并喹喔啉和二咪唑并喹唑啉对克隆的GABAA受体的α1β2γ2和α6β2γ2亚型的差异亲和力。
Br J Pharmacol. 1993 Oct;110(2):677-80. doi: 10.1111/j.1476-5381.1993.tb13864.x.
6
A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists.一种用于药效团映射的快速新方法及其在多巴胺能和苯二氮䓬类激动剂中的应用。
J Comput Aided Mol Des. 1993 Feb;7(1):83-102. doi: 10.1007/BF00141577.
7
Differential potentiation of GABAA receptor function by two stereoisomers of diimidazoquinazoline analogues.二咪唑喹唑啉类似物的两种立体异构体对GABAA受体功能的差异增强作用。
Br J Pharmacol. 1992 Oct;107(2):622-7. doi: 10.1111/j.1476-5381.1992.tb12793.x.
4
CGS 8216: receptor binding characteristics of a potent benzodiazepine antagonist.
Life Sci. 1982 Jan 25;30(4):363-72. doi: 10.1016/0024-3205(82)90573-2.
5
Molecular heterogeneity of benzodiazepine receptors.苯二氮䓬受体的分子异质性
Nature. 1980 Jul 17;286(5770):285-7. doi: 10.1038/286285a0.
6
Benzodiazepine interactions with GABA receptors.苯二氮䓬类药物与γ-氨基丁酸(GABA)受体的相互作用。
Neurosci Lett. 1984 Jun 29;47(3):201-6. doi: 10.1016/0304-3940(84)90514-7.
7
Beta-carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors.β-咔啉:脑苯二氮䓬受体的合成、神经化学及药理作用
J Med Chem. 1982 Sep;25(9):1081-91. doi: 10.1021/jm00351a015.
8
2-Arylpyrazolo[4,3-c]quinolin-3-ones: novel agonist, partial agonist, and antagonist of benzodiazepines.
J Med Chem. 1982 Apr;25(4):337-9. doi: 10.1021/jm00346a002.
9
Synthesis and anxiolytic activity of 6-(substituted-phenyl)-1,2,4-triazolo[4,3-b]pyridazines.
J Med Chem. 1981 May;24(5):592-600. doi: 10.1021/jm00137a020.
10
Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors.PK 8165作为脑型苯二氮䓬受体部分激动剂的药理学证据。
Arch Int Pharmacodyn Ther. 1984 Oct;271(2):189-97.